Plasticity of fetal cartilaginous cells

Cell Transplantation

Volumn 19, Issue 10, 2010, Pages 1349-1357

  Quintin, Aurelie ^a,b   Schizas, Constantin ^a   Scaletta, Corinne ^a   Jaccoud, Sandra ^a   Applegate, Lee Ann ^a   Pioletti, Dominique P ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Chondrogenesis; Fetal cells; Plasticity; Stem cells

Indexed keywords

AGGRECAN; CELL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; TRANSFORMING GROWTH FACTOR BETA3;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CARTILAGE CELL; CARTILAGINOUS TISSUE; CELL DIFFERENTIATION; CELL ISOLATION; CELL TYPE; CHONDROGENESIS; CONTROLLED STUDY; DENSITY; FETUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

AGGRECANS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN TYPE I; COLLAGEN TYPE II; COLLAGEN TYPE X; FEMUR HEAD; FETUS; HUMANS; SPINE; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA3;

EID: 78650923935     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X506854     Document Type: Article

References (47)

1. Akesson, E.; Markling, L.; Kjaeldgaard, A.; Falci, S.; Ringden, O. MHC antigen expression in human first trimester spinal cord with implications for clinical transplantation procedures. J. Neuroimmunol. 111(1-2):210-214; 2000.
2. Arthur, A.; Zannettino, A.; Gronthos, S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218(2):237- 245; 2009.
3. Barbero, A.; Ploegert, S.; Heberer, M.; Martin, I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 48(5):1315- 1325; 2003.
4. Barry, F.; Boynton, R. E.; Liu, B.; Murphy, J. M. Chon-drogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation- dependent gene expression of matrix components. Exp. Cell Res. 268(2):189-200; 2001.
5. Bianchi, G.; Banfi, A.; Mastrogiacomo, M.; Notaro, R.; Luzzatto, L.; Cancedda, R.; Quarto, R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp. Cell Res. 287(1):98-105; 2003.
6. Brittberg, M. Autologous chondrocyte implantation- technique and long-term follow- up. Injury 39(Suppl. 1): S40-49; 2008.
7. Brittberg, M.; Lindahl, A.; Nilsson, A.; Ohlsson, C.; Isak-sson, O.; Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331(14):889-895; 1994.
8. Campagnoli, C.; Roberts, I. A.; Kumar, S.; Bennett, P. R.; Bellantuono, I.; Fisk, N. M. Identification of mesenchy-mal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98(8):2396-2402; 2001.
9. Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213(2):341-347; 2007.
10. Cui, Y.; Wang, H.; Yu, M.; Xu, T.; Li, X.; Li, L. Differentiation plasticity of human fetal articular chondrocytes. Otolaryngol. Head Neck Surg. 135(1):61-67; 2006.
11. Das, R. H.; Jahr, H.; Verhaar, J. A.; van der Linden, J. C.; van Osch, G. J.; Weinans, H. In vitro expansion affects the response of chondrocytes to mechanical stimulation. Osteoarthritis Cartilage 16(3):385-391; 2008..
12. De Buys Roessingh, A. S.; Hohlfeld, J.; Scaletta, C.; Hirt-Burri, N.; Gerber, S.; Hohlfeld, P.; Gebbers, J. O.; Applegate, L. A. Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant. 15(8-9):823-834; 2006.
13. Dell'Accio, F.; De Bari, C.; Luyten, F. P. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp. Cell Res. 287(1):16-27; 2003.
14. Dominici, M.; Blanc, K. L.; Mueller, I.; Slaper-Corten-bach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytother-apy 8(4):315-317; 2006.
15. Foglia, R. P.; DiPreta, J.; Statter, M. B.; Donahoe, P. K. Fetal allograft survival in immunocompetent recipients is age dependent and organ specific. Ann. Surg. 204(4):402-410; 1986.
16. Giannoni, P.; Pagano, A.; Maggi, E.; Arbico, R.; Randaz-zo, N.; Grandizio, M.; Cancedda, R.; Dozin, B. Autolo-gous chondrocyte implantation (ACI) for aged patients: Development of the proper cell expansion conditions for possible therapeutic applications. Osteoarthritis Cartilage 13(7):589-600; 2005.
17. Gotherstrom, C.; Ringden, O.; Tammik, C.; Zetterberg, E.; Westgren, M.; Le Blanc, K. Immunologic properties of human fetal mesenchymal stem cells. Am. J. Obstet. Gyn-ecol. 190(1):239-245; 2004.
18. Hiyama, A.; Mochida, J.; Sakai, D. Stem cell applications in intervertebral disc repair. Cell. Mol. Biol. 54(1):24-32; 2008.
19. Ho, A.; Wagner, W.; Franke, W. Heterogeneity of mesen-chymal stromal cell preparations. Cytotherapy 10(4):320-330; 2008.
20. Hohlfeld, J.; de Buys Roessingh, A.; Hirt-Burri, N.; Chaubert, P.; Gerber, S.; Scaletta, C.; Hohlfeld, P.; Applegate, L. A. Tissue engineered fetal skin constructs for pae-diatric burns. Lancet 366(9488):840-842; 2005.
21. Ichinose, S.; Yamagata, K.; Sekiya, I.; Muneta, T.; Tagami, M. Detailed examination of cartilage formation and endochondral ossification using human mesenchymal stem cells. Clin. Exp. Pharmacol. Physiol. 32(7):561-570; 2005. (Pubitemid 41021070)
22. in't Anker, P. S.; Noort, W. A.; Scherjon, S. A.; Kleij-burg-van der Keur, C.; Kruisselbrink, A. B.; van Bezooijen, R. L.; Beekhuizen, W.; Willemze, R.; Kanhai, H. H.; Fibbe, W. E. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88(8):845-852; 2003.
23. Jo, C. H.; Kim, O. S.; Park, E. Y.; Kim, B. J.; Lee, J. H.; Kang, S. B.; Han, H. S.; Rhee, S. H.; Yoon, K. S. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res. 334(3):423-433; 2008.
24. Karlsson, C.; Brantsing, C.; Svensson, T.; Brisby, H.; Asp, J.; Tallheden, T.; Lindahl, A. Differentiation of human mesenchymal stem cells and articular chondrocytes: Analysis of chondrogenic potential and expression pattern of differentiation-related transcription factors. J. Orthop. Res. 25(2):152-163; 2007.
25. Kluba, T.; Niemeyer, T.; Gaissmaier, C.; Grunder, T. Human anulus fibrosis and nucleus pulposus cells of the intervertebral disc: Effect of degeneration and culture system on cell phenotype. Spine 30(24):2743-2748; 2005.
26. Kumahashi, N.; Ochi, M.; Kataoka, H.; Uchio, Y.; Kaki-maru, H.; Sugawara, K.; Enomoto, K. Involvement of ATP, increase of intracellular calcium and the early expression of c-fos in the repair of rat fetal articular cartilage. Cell Tissue Res. 317(2):117-128; 2004.
27. Kuroda, R.; Ishida, K.; Matsumoto, T.; Akisue, T.; Fujioka, H.; Mizuno, K.; Ohgushi, H.; Wakitani, S.; Kurosaka, M. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15(2):226-231; 2007.
28. Meisel, H. J.; Ganey, T.; Hutton, W. C.; Libera, J.; Mink-us, Y.; Alasevic, O. Clinical experience in cell-based therapeutics: Intervention and outcome. Eur. Spine J. 15(Suppl. 3):S397-405; 2006.
29. Montjovent, M. O.; Bocelli-Tyndall, C.; Scaletta, C.; Scherberich, A.; Mark, S.; Martin, I.; Applegate, L. A.; Pioletti, D. P. In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications. Tissue Eng. Part A 15(7):1523-1532; 2009.
30. Mwale, F.; Stachura, D.; Roughley, P.; Antoniou, J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J. Orthop. Res. 24(8):1791-1798; 2006.
31. Namba, R. S.; Meuli, M.; Sullivan, K. M.; Le, A. X.; Adzick, N. S. Spontaneous repair of superficial defects in articular cartilage in a fetal lamb model. J. Bone Joint Surg. Am. 80(1):4-10; 1998.
32. Pelttari, K.; Winter, A.; Steck, E.; Goetzke, K.; Hennig, T.; Ochs, B. G.; Aigner, T.; Richter, W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 54(10):3254-3266; 2006.
33. Peterson, L.; Minas, T.; Brittberg, M.; Nilsson, A.; Sjog-ren-Jansson, E.; Lindahl, A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin. Orthop. Relat. Res. (374):212-234; 2000.
34. Pioletti, D. P.; Montjovent, M. O.; Zambelli, P. Y.; Applegate, L. Bone tissue engineering using foetal cell therapy. Swiss Med. Wkly. 136(35-36):557-560; 2006.
35. Quintin, A.; Hirt-Burri, N.; Scaletta, C.; Schizas, C.; Pioletti, D. P.; Applegate, L. A. Consistency and safety of cell banks for research and clinical use: Preliminary analysis of fetal skin banks. Cell Transplant. 16(7):675-684; 2007.
36. Slack, J. M. W. Origin of stem cells in organogenesis. Science 322(5907):1498-1501; 2008.
37. Solchaga, L. A.; Penick, K.; Porter, J. D.; Goldberg, V. M.; Caplan, A. I.; Welter, J. F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 203(2):398-409; 2005.
38. Stone, C. A. Unravelling the secrets of foetal wound healing: An insight into fracture repair in the mouse foetus and perspectives for clinical application. Br. J. Plast. Surg. 53(4):337-341; 2000.
39. Tallheden, T.; Dennis, J. E.; Lennon, D. P.; Sjogren-Jans-son, E.; Caplan, A. I.; Lindahl, A. Phenotypic plasticity of human articular chondrocytes. J. Bone Joint Surg. Am. 85(Suppl. 2):93-100; 2003.
40. Thornemo, M.; Tallheden, T.; Sjogren Jansson, E.; Lars-son, A.; Lovstedt, K.; Nannmark, U.; Brittberg, M.; Lindahl, A. Clonal Populations of chondrocytes with progenitor properties identified within human articular cartilage. Cells Tissues Organs 180(3):141-150; 2005.
41. Tsutsumi, S.; Shimazu, A.; Miyazaki, K.; Pan, H.; Koike, C.; Yoshida, E.; Takagishi, K.; Kato, Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 288(2):413-419; 2001.
42. Wakitani, S.; Mitsuoka, T.; Nakamura, N.; Toritsuka, Y.; Nakamura, Y.; Horibe, S. Autologous bone marrow stro-mal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports. Cell Transplant. 13(5):595-600; 2004.
43. Wakitani, S.; Nawata, M.; Tensho, K.; Okabe, T.; Machida, H.; Ohgushi, H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: Three case reports involving nine defects in five knees. J. Tissue Eng. Regen. Med. 1(1):74-79; 2007.
44. Wei, Y.; Sun, X.; Wang, W.; Hu, Y. Adipose-derived stem cells and chondrogenesis. Cytotherapy 9(8):712-716; 2007.
45. Yoo, J. U.; Barthel, T. S.; Nishimura, K.; Solchaga, L.; Caplan, A. I.; Goldberg, V. M.; Johnstone, B. The chon-drogenic potential of human bone-marrow-derived mesen-chymal progenitor cells. J. Bone Joint Surg. Am. 80(12): 1745-1757; 1998.
46. Zahir, T.; Nomura, H.; Guo, X. D.; Kim, H.; Tator, C.; Morshead, C.; Shoichet, M. Bioengineering neural stem/ progenitor cell-coated tubes for spinal cord injury repair. Cell Transplant. 17(3):245-254; 2008.
47. Zou, X. H.; Cai, H. X.; Yin, Z.; Chen, X.; Jiang, Y. Z.; Hu, H.; Ouyang, H. W. A novel strategy incorporated the power of mesenchymal stem cells to allografts for segmental bone tissue engineering. Cell Transplant. 18(4): 433-441; 2009